InvestorsHub Logo
Followers 154
Posts 2652
Boards Moderated 0
Alias Born 01/29/2004

Re: plexrec post# 328524

Wednesday, 09/01/2021 9:23:35 AM

Wednesday, September 01, 2021 9:23:35 AM

Post# of 463624
The science, and it's evidence. superbly presented.

Parkinson's Article--...falconer, care to comment???


https://scienceofparkinsons.com/2021/06/29/anavex/

Well, just superb.

As a former advanced placement biology teacher, tasked with teaching very talented students in an up-scale high school, where all of the selected students in my class were destined for high-level college majors, most of them in the sciences, I always cringed when really good people would comment that "Those teachers got it so easy. Just stand up there and talk for 50 minutes four times a day, for just nine months of the year. They think they are underpaid. Ha!"

Well, of course, there are teachers that do that, merely babble forth in each class, conveying little that is significant, important, or well-prepared. Not the case with either me, or the person who constructed this website. Read it, closely. With determined time and effort, the author has very clearly and intelligently laid out the science (and it's evidence) for blarcamesine as a Parkinson's therapeutic. I would have loved to have this fellow on my science teaching facility. Everything is laid out clearly, in useful sequence, allowing interested students to accurately percieve and understand what's being presented.

Of course, what was presented was Anavex science, and how it successfully treats Parkinson's disease. Think the on-going Parkinson's disease dementia trail, when it ends not long from now, will be a failure? Read this graphically-illustrated website again.

Thanks for the invitation to comment on it. For this information, a privilege. I would now invite contrary views. Anyone, show us how this information is in error; how it does not accurately portend blarcamesine's success against either Parkinson's disease in general, or Parkinson's disease dementia in particular.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News